Le Lézard
Classified in: Health
Subject: PER

Pharma and medical devices expert Marck Aghnatios joins PA Consulting


NEW YORK, Jan. 14, 2020 /PRNewswire/ -- Marck Aghnatios has joined PA Consulting (PA), the consultancy that's bringing ingenuity to life, to expand PA's medtech and medical device capabilities in the US healthcare and life sciences sectors. He is focused on supporting medtech clients with innovation, transformation, and regulatory changes.

PA has been developing medical devices for decades and has an extensive history of innovation. PA has developed notable technological advancements, including pioneering the modern asthma inhaler, developing innovative wearable devices that monitor the health of unborn babies at home and in the hospital for Monica Healthcare, part of the GE Healthcare family, and creating the Orbital® inhaler for Pharmaxis which is being used in key research to combat tuberculosis.

PA's extensive medical device development capabilities ? including laboratory, design, and build facilities ? are housed at Essential Design, a Boston-based innovation strategy and product design business that PA acquired in 2018, and at our Global Innovation and Technology Center in Cambridge, UK. 

Marck is a pharmaceutical and medical devices expert with a strong consulting track record. He joins PA from KPMG where he worked with life sciences clients on R&D, quality, regulatory, supply chain, and packaging projects. Throughout his career, Marck has demonstrated that he is an outstanding leader who leverages creativity and out of the box thinking to successfully identify business opportunities and build innovative teams.  

George Botsakos, global head of health and life sciences at PA Consulting, says: "At PA, ingenuity is in our DNA. We are continuing to grow in the US and are recruiting world-class talent. Marck has deep experience in life sciences and brings relevant, pragmatic insight that will help our clients create opportunity from complexity."  

Marck Aghnatios, life sciences and medical device expert at PA Consulting, says: "I am thrilled to join PA, with its unique end-to-end innovation capabilities and strong consultant network that differentiate it from competitors in the US market. PA is leading on very exciting projects that will make a tangible impact on improving people's lives. I am looking forward to helping PA's clients push innovative medical devices and instrumentation to market further, faster."   

About PA Consulting 
We believe in the power of ingenuity to build a positive human future in a technology-driven world. As strategies, technologies and innovation collide, we create opportunity from complexity. Our diverse teams of experts combine innovative thinking and breakthrough technologies to progress further, faster. Our clients adapt and transform, and together we achieve enduring results. An innovation and transformation consultancy, we are over 3,000 specialists in consumer, defense and security, energy and utilities, financial services, government, healthcare, life sciences, manufacturing, and transport, travel and logistics. We operate globally from offices across the Americas, Europe, the Nordics and the Gulf. www.paconsulting.com 

SOURCE PA Consulting


These press releases may also interest you

at 02:05
PureTech Health plc ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on Thursday, April 25, 2024. A presentation and conference call to discuss the results...

at 01:30
The shares in Aker ASA will be traded ex-dividend NOK 15.50 as from today, 18 April 2024. Investor contact:Fredrik Berge, Head of Investor Relations Aker ASA Tel: +47 450 32 090 E-mail: [email protected] Media contact:Atle Kigen, Head of...

at 00:00
Health Carousel, renowned for its dedication to enhancing the healthcare staffing sector, today unveiled its groundbreaking 'Full Circle of Support' program. This initiative represents a significant investment in the total well-being of its...

17 avr 2024
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...

17 avr 2024
SysInformation Healthcare Services, LLC ("SysInformation"), d/b/a EqualizeRCM and 1st Credentialing, is providing notice of a recent data security event that may affect the security of information related to certain individuals. SysInformation is...

17 avr 2024
Scottie Resources Corp. ("Scottie" or the "Company") announces that it has granted 7,400,000 options to acquire common shares to certain directors, officers, and consultants to the Company. The options are exercisable at a price of $0.195 per...



News published on and distributed by: